Vol 80, No 3 (2022)
Clinical vignette
Published online: 2022-01-18
Transcatheter treatment tricuspid regurgitation by valve-in-ring implantation with a novel balloon-expandable Myval® THV
Abstract
Not available
References
- McElhinney DB, Aboulhosn JA, Dvir D, et al. Mid-Term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol. 2019; 73(2): 148–157.
- Gerçek M, Schramm R, Paluszkiewicz L, et al. A case report: intravalvular regurgitation during percutaneous valve-in-ring implantation due to eccentric bulging of a balloon-expandable valve in a patient with severe right heart failure. Eur Heart J Case Rep. 2019; 3(4): 1–6.
- Faure ME, van Mieghem NM, Budde RPJ. Transcatheter tricuspid valve-in-ring placement: complex valve obstruction by hypo-attenuating leaflet thickening, hypo-attenuation affecting motion, and native tricuspid valve remnant. Eur Heart J. 2020; 41(8): 973.
- Noble S, Myers PO, Hachulla AL, et al. Unsuccessful transfemoral tricuspid valve-in-ring implantation: case report and literature review. CJC Open. 2019; 1(6): 330–334.
- Aboulhosn J, Cabalka AK, Levi DS, et al. Transcatheter valve-in-ring implantation for the treatment of residual or recurrent tricuspid valve dysfunction after prior surgical repair. JACC Cardiovasc Interv. 2017; 10(1): 53–63.
